Articles by Moe Alsumidaie - Applied Clinical Trials


Articles by Moe Alsumidaie

Moe Alsumidaie

Highlights from the 2014 Patient Centered Clinical Trials Symposium
September 9, 2014

Eye for Pharma hosted its first Patient Centered Clinical Trials symposium in Boston.

Aggregated EMR: How Study Sites Can Develop a Collaborative Subject Enrollment Infrastructure
August 28, 2014

In this Electronic Medical Records blog series, we explained the basics of Aggregated EMR.

Aggregated EMR: Mitigating Trial Risk through Quality by Design Protocols
August 27, 2014

Cultural factors embedded in clinical operations groups, such as focusing on First Patient in deadlines takes away from the quality of a robustly designed protocol.

Medical Marijuana Clinical Trials: Preempted by Politics
August 14, 2014

There has been a lot of debate on the therapeutic use of marijuana.

Kadmon CEO Discusses Biopharma Innovation
August 5, 2014

While at the 2014 NYBIO conference, Dr. Sam Waksal from Kadmon had the opportunity to address the audience regarding the state of the biopharmaceutical industry.

The Future of Subject Enrollment: Aggregated EMR
July 29, 2014

The topic of subject enrollment has been evaluated from many different perspectives.

FDA Sentinel: Catching Biopharmaceutical Sponsors by Surprise
July 24, 2014

This article will discuss FDA's post-marketing surveillance programs, and how biopharmaceutical sponsors can work with the FDA to identify unreported Adverse Events.

Highlights from the 2014 DIA Annual Meeting in San Diego
June 26, 2014

DIA held its 2014 annual meeting in San Diego and attracted thousands of attendees from around the globe.

FDA's Margaret Hamburg: Angle on Patient Engagement and Regulatory Systems Reform
June 10, 2014

While at the 2014 New York BIO conference, FDA Commissioner, Dr. Margaret Hamburg, had the opportunity to address pressing issues affecting the biopharmaceutical industry and the FDA.



Untitled Document
Click here